1323140-59-5 Usage
Description
(Z)-N-(1-chloro-3-oxo-3-(piperidin-1-yl)-1-o-tolylprop-1-en-2-yl)benzamide is a chemical compound with potential pharmaceutical applications. It is a derivative of benzamide that contains a piperidin-1-yl group and a chloro substituent. (Z)-N-(1-chloro-3-oxo-3-(piperidin-1-yl)-1-o-tolylprop-1-en-2-yl)benzamide has been studied for its potential as an antitumor and anticancer agent, with research showing promising results in inhibiting the growth of cancer cells. Additionally, it has potential as a therapeutic agent for other medical conditions, and research is ongoing to explore its pharmacological properties. Overall, (Z)-N-(1-chloro-3-oxo-3-(piperidin-1-yl)-1-o-tolylprop-1-en-2-yl)benzamide is a compound of interest in the pharmaceutical industry for its potential therapeutic benefits.
Uses
Used in Pharmaceutical Industry:
(Z)-N-(1-chloro-3-oxo-3-(piperidin-1-yl)-1-o-tolylprop-1-en-2-yl)benzamide is used as an antitumor and anticancer agent for its potential to inhibit the growth of cancer cells. Research has shown promising results in this area, making it a compound of interest for further study and development.
Used in Oncology Research:
In the field of oncology, (Z)-N-(1-chloro-3-oxo-3-(piperidin-1-yl)-1-o-tolylprop-1-en-2-yl)benzamide is used as a compound for studying its potential therapeutic effects on various types of cancer. Its ability to inhibit cancer cell growth makes it a valuable candidate for further research and potential development as a treatment option.
Used in Drug Development:
(Z)-N-(1-chloro-3-oxo-3-(piperidin-1-yl)-1-o-tolylprop-1-en-2-yl)benzamide is also used in drug development as a potential therapeutic agent for other medical conditions. Ongoing research aims to explore its pharmacological properties and determine its potential for treating a range of diseases beyond cancer.
Used in Preclinical Trials:
As a compound with potential therapeutic benefits, (Z)-N-(1-chloro-3-oxo-3-(piperidin-1-yl)-1-o-tolylprop-1-en-2-yl)benzamide is used in preclinical trials to evaluate its safety, efficacy, and potential side effects before it can be considered for use in humans. These trials are crucial for determining the compound's viability as a pharmaceutical agent.
Check Digit Verification of cas no
The CAS Registry Mumber 1323140-59-5 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,3,2,3,1,4 and 0 respectively; the second part has 2 digits, 5 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 1323140-59:
(9*1)+(8*3)+(7*2)+(6*3)+(5*1)+(4*4)+(3*0)+(2*5)+(1*9)=105
105 % 10 = 5
So 1323140-59-5 is a valid CAS Registry Number.
1323140-59-5Relevant articles and documents
Synthesis and quantitative structure-activity relationships study for phenylpropenamide derivatives as inhibitors of hepatitis B virus replication
Yang, Jing,Ma, Min,Wang, Xue-Ding,Jiang, Xing-Jun,Zhang, Yuan-Yuan,Yang, Wei-Qing,Li, Zi-Cheng,Wang, Xi-Hong,Yang, Bin,Ma, Meng-Lin
, p. 82 - 91 (2015/07/27)
A series of new phenylpropenamide derivatives containing different substituents was synthesized, characterized and evaluated for their anti-hepatitis B virus (HBV) activities. The quantitative structure eactivity relationships (QSAR) of phenylpropenamide compound have been studied. The 2D-QSAR models, based on DFT and multiple linear regression analysis methods, revealed that higher values of total energy (TE) and lower entropy (Sθ) enhanced the anti-HBV activities of the phenylpropenamide molecules. Predictive 3D-QSAR models were established using SYBYL multifit molecular alignment rule. The optimum models were all statistically significant with cross-validated and conventional coefficients, indicating that they were reliable enough for activity prediction.
